![The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysis]()
The magnitude of improvement in progression-free survival with targeted therapy in relapsed/refractory chronic lymphocytic leukemia based on prognostic risk category: a systematic review and meta-analysisMolica, Stefano; Giannarelli, Diana; Mirabelli, Rosanna; Levato, Luciano; Shanafelt, Tait D. · Leukemia & Lymphoma · 2018